Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Dermata Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results"
08/03/2023 8-K Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Second Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan",
"Letter of Mayer Hoffman McCann P.C. to the Securities and Exchange Commission"
05/24/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Form of Pre-Funded Warrant",
"Form of Warrant",
"Form of Placement Agent Warrant",
"Opinion of Lowenstein Sandler LLP",
"Form of Securities Purchase Agreement, by and between the Company and the Purchasers",
"Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules"
05/11/2023 8-K Quarterly results
Docs: "Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results"
03/28/2023 8-K Quarterly results
03/20/2023 8-K Quarterly results
03/13/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "CERTIFICATE"
02/08/2023 8-K Quarterly results
12/15/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ...
12/05/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea"
09/23/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amendment to Amended and Restated Bylaws"
08/15/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
06/22/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/25/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Common Stock Warrant",
"Form of Pre Funded Warrant",
"Form of Securities Purchase Agreement between the Company and the Purchaser",
"Form of Registration Rights Agreement between the Company and the Purchaser",
"Form of Placement Agent Agreement between the Company and the Placement Agent",
"Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules",
"Dermata Therapeutics Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules"
03/28/2022 8-K Quarterly results
03/02/2022 8-K Quarterly results
02/04/2022 8-K Other Events  Interactive Data
01/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Dermata Appoints Life Science Executive Brittany Bradrick to Board of Directors"
12/10/2021 8-K Quarterly results
11/19/2021 8-K Regulation FD Disclosure, Other Events  Interactive Data
Docs: "Dermata Announces Positive Results from DMT410 Phase 1b Proof of Concept Study for Aesthetic Skin Conditions"
09/27/2021 8-K Quarterly results
09/01/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy